Tag: PTC Therapeutics

Muscular dystrophy

BioMarin Pharmaceutical

Click the tags to see associated articles and topics

View Article Details

Analyst Reaffirms Positive Outlook on PTC Therapeutics with Adjusted Price Target

Added to Collection on: 2023-09-18 18:34:04

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

PTC to sell spinal muscular atrophy drug royalties for $1B | BioPharma Dive

Added to Collection on: 2023-10-19 15:57:46

Tags for this article:

Duchenne muscular dystrophy

Click the tags to see associated articles and topics

View Article Details

CHMP Issues Negative Opinion for Renewal of Conditionally Approved Therapy Ataluren

Added to Collection on: 2024-01-31 20:12:20

Tags for this article:

Duchenne muscular dystrophy

Nonsense mutation

Placebo

Click the tags to see associated articles and topics

View Article Details

FDA Nod in Duchenne Helps Wider Swath of Patients With the Rare Muscle Disease

Added to Collection on: 2024-03-22 16:51:13

Tags for this article:

Applied genetics

Deflazacort

Delandistrogene moxeparvovec

Click the tags to see associated articles and topics

View Article Details

Nike, Kura Sushi fall; Infinera, Protagonist Therapeutics rise, Friday, 6/28/2024

Added to Collection on: 2024-06-28 21:50:08

Tags for this article:

Duchenne

Click the tags to see associated articles and topics

View Article Details

Vanguard Group Inc. Buys 855,354 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT)

Added to Collection on: 2024-07-02 12:31:31

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

First Brain-Injected Gene Therapy Approved by FDA | MDedge

Added to Collection on: 2024-11-19 18:11:03

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

1st gene therapy delivered directly into brain approved - Becker's Hospital Review

Added to Collection on: 2024-11-20 15:39:38

Tags for this article:

Rare diseases